Veritas Is Studying the DNA of People Who Live to 110, Looking for Clues to Longevity

August 20, 2018

(CNBC) – Veritas, located north of Boston, is among a handful of emerging companies providing the tools for humans to map their genome at a price, $1,000 each, that almost brings it into the mainstream. When Steve Jobs, the late Apple CEO, had his DNA sequenced while battling pancreatic cancer in 2011, it cost him $100,000. But in addition to selling kits to consumers who want to dive deep into their biological code, Veritas is doing research into people like Dellis to try and understand how and why extraordinary people are different.